Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Por um escritor misterioso

Last updated 06 março 2025

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Brain Sciences, Free Full-Text

Efficacy and safety of brexpiprazole in acute management of psychiatric disorders: a meta-analysis of randomized controlled trials

Biomedicines, Free Full-Text

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: What's the Impact?

Full article: Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies

What you need to know about Rexulti (Brexpiprazole)

The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open

Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning

PDF] Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

Brexpiprazole, CAS:913611-97-9, 5-HT2A, α1B-, and α2C-adrenergic receptors antagonist, High Purity

Brexpiprazole Short-Term Clinical Study Designs for the Adjunctive

Recomendado para você